This bill amends Title XVIII of the Social Security Act across several narrow but operationally significant areas. It carries temporary extensions and targeted adjustments for Medicare telehealth and home-based care authorities, creates new program‑integrity hooks for durable medical equipment and certain lab tests, and directs guidance and studies intended to shape how virtual services are delivered and measured.
For providers and payers the bill is mostly about compliance and coding: it changes payment treatment for certain telehealth encounters, requires specific reporting and study mandates for the hospital-at-home model, adds prepayment review authority tied to a DME “Master List,” and tasks HHS and the OIG with guidance and analyses that will drive future rulemaking. Those shifts affect billing, audit risk, and operational design for virtual care programs and suppliers.
At a Glance
What It Does
The bill continues a set of temporary Medicare telehealth flexibilities, adjusts how FQHCs and rural health clinics are paid for telehealth services, delays certain in‑person requirements for mental‑health televisits, and authorizes audio‑only services for an extended period. It also extends and studies the Acute Hospital Care at Home waiver, adds DME-focused program‑integrity authority, mandates an OIG assessment of lab‑test fraud risks, and expands virtual participation in the Medicare Diabetes Prevention Program.
Who It Affects
Medicare clinicians, hospitals that operate or plan hospital‑at‑home programs, FQHCs and rural health clinics, DME suppliers, clinical diagnostic laboratories, telehealth vendors, beneficiary populations with limited English proficiency, and organizations that deliver digital diabetes prevention services.
Why It Matters
The package preserves access mechanisms created during prior emergency periods while layering new compliance checkpoints. That combination can sustain virtual care growth in the near term but will also increase coding and audit complexity for providers and suppliers—pushing CMS to define details that will matter for billing, coverage, and operational models.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill is a collection of discrete amendments focused on how Medicare pays for and oversees virtual and home‑based care. It renews temporary telehealth authorities that relax geographic and originating‑site limits and broadens the list of practitioner types eligible to furnish telehealth, while extending permissive treatment of audio‑only encounters.
For FQHCs and rural health clinics the legislation preserves a payment path that treats certain telehealth visits as FQHC/RHC services under applicable prospective payment or all‑inclusive rate methodologies, and it creates a limited transitional payment rule for services furnished during the specified extension period.
On mental‑health care, the bill postpones the restoration of required in‑person evaluations tied to certain telehealth visits; related statutory cross‑references are updated so rural health clinics and FQHCs operate under the delayed timetable. For hospice recertification the statute is amended to allow a telehealth encounter to satisfy the face‑to‑face requirement in more circumstances, but claims for such encounters must carry CMS‑specified modifiers beginning in the first year after enactment.Separately, the legislation extends the authority for hospitals to operate Acute Hospital Care at Home waivers and directs HHS to conduct a detailed subsequent study.
That study must compare outcome, cost, utilization, patient/caregiver experience, and equity‑related metrics across participating and nonparticipating hospitals and control, to the extent practicable, for selection bias. The Secretary must report the results to congressional health committees.To tighten program integrity, the bill adds a DME‑focused provision that permits CMS to flag items with aberrant billing patterns for inclusion on a Master List and to subject such items to prepayment review beginning on a set future date; the same approach is applied to prosthetics and orthotics where applicable.
The Inspector General must deliver a separate report evaluating clinical diagnostic laboratory tests at high risk for fraudulent claims and recommend mitigation tools.Finally, the bill requires HHS to issue best‑practice guidance for furnishing telehealth to individuals with limited English proficiency in consultation with a range of stakeholders; authorizes temporary in‑home cardiopulmonary rehabilitation via real‑time audio‑video communications (with CMS allowed to implement by program instruction); and directs regulatory changes to allow virtual‑only suppliers to enroll in the Medicare Diabetes Prevention Program, including interstate claims submission and removal of repeat‑enrollment limits for a multi‑year period.
The Five Things You Need to Know
The bill extends existing temporary Medicare telehealth flexibilities and the permissive treatment of audio‑only encounters through September 30, 2027.
Hospice face‑to‑face recertification encounters may be conducted via telehealth in additional circumstances, but hospice claims for such encounters must include CMS‑specified modifiers for encounters occurring on or after January 1, 2026.
The Acute Hospital Care at Home authority is extended through 2030 and requires the Secretary to deliver a detailed comparative study and report to Congress by September 30, 2028, that must address outcomes, costs, readmissions, and selection‑bias controls.
Beginning January 1, 2028, CMS may include items with aberrant DME billing patterns on the Master List and subject those items to prepayment review; the amendment explicitly extends that treatment to prosthetics and orthotics.
Regulatory changes will allow entities offering only online Medicare Diabetes Prevention Program services to enroll and bill from January 1, 2026 through December 31, 2030, permit interstate billing by such suppliers, and remove limits on the number of times an individual may enroll.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Establishes the act’s name as the "Telehealth Modernization Act." This is purely stylistic but sets the label under which implementing guidance and rulemaking will be referenced.
Extending and expanding telehealth flexibilities
Amends section 1834(m) and related provisions to push the sunset dates for geographic restrictions, originating‑site rules, eligible practitioner types, FQHC/RHC telehealth treatment, audio‑only services, and other temporary waivers to a unified later date. Practically, CMS and Medicare Administrative Contractors will continue to process claims under the relaxed rules for the specified extension window; contractors will need to keep coding tables and coverage edits synchronized with these statutory dates to avoid denials.
Hospice face‑to‑face encounters and modifier requirement
Modifies the hospice face‑to‑face encounter rule to allow telehealth to satisfy the in‑person requirement in certain exempt situations and then adds a claims‑coding requirement: for encounters on or after the statutory modifier start date, hospices must append CMS‑specified modifiers or codes indicating the encounter was via telehealth. This is an operational change that requires hospices to update electronic health record templates, billing systems, and internal audit protocols to capture and report the new modifiers or risk improper payment for untimely modifier adoption.
Acute Hospital Care at Home—extension and mandated study
Extends the waiver authority duration and creates a substantive reporting requirement. The Secretary must perform a multi‑axis comparative analysis—covering clinical outcomes, readmissions (including beyond 30 days), staffing mixes, costs, and equity metrics—and account for selection bias to the extent possible. Hospitals operating hospital‑at‑home programs should plan for increased data collection and documentation, since the study will likely rely on granular, linkable data elements that go beyond typical claims fields.
DME master‑list authority and lab‑fraud report
Adds a new paragraph to section 1834(a) authorizing CMS to treat items as showing aberrant billing when many claims for an item originate with a prescriber who has not furnished services to the beneficiary in the prior 24 months, and to subject such items to prepayment review after inclusion on the Master List. A conforming provision applies the approach to prosthetics/orthotics. Separately, the OIG is directed to identify clinical diagnostic laboratory tests at high risk of fraudulent claims and recommend mitigations; that OIG work will inform targeted audits, education, and potential coverage or payment rule changes.
LEP telehealth guidance
Requires HHS to issue or update best‑practice guidance within one year on integrating interpreters, multilingual patient materials, accessible instructions for telehealth platforms, and multi‑person video interpretation workflows. HHS must consult a broad set of stakeholders—technology vendors, providers, insurers, language service companies, certifiers, and patient advocates—so the guidance will be implementation‑focused but nonbinding unless folded into regulation or conditions of participation.
In‑home cardiopulmonary rehabilitation flexibilities
Amends the definition of covered outpatient hospital services to explicitly permit the furnishing of cardiopulmonary rehab items and services via real‑time audio‑video communications (excluding audio‑only) for a defined temporary period and clarifies that virtual presence of supervising clinicians counts for program participation. The Secretary may implement these changes by program instruction, meaning CMS can operationalize payment and documentation rules quickly without a formal notice‑and‑comment rulemaking.
Virtual MDPP supplier enrollment and billing rules
Directs HHS to revise regulations so that entities offering only online Diabetes Prevention Program services may enroll as MDPP suppliers for a multi‑year period, allows such suppliers to use their administrative location for enrollment, permits billing when beneficiaries are out‑of‑state at time of service, and removes limits on the number of MDPP enrollments by an individual during the covered period. This will require CMS to update supplier enrollment checks, the Medicare billing system, and oversight processes for remote suppliers.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Rural and homebound Medicare beneficiaries — maintain expanded access to care delivered remotely (including audio‑only where clinically appropriate) and face fewer geographic limits when seeking specialists or follow‑up care.
- Hospice patients in areas with hospice moratoria or enhanced oversight — gain continued flexibility to use telehealth for required face‑to‑face recertifications when exceptions apply, reducing travel and access barriers.
- Participants in hospital‑at‑home and virtual MDPP programs — benefit from extended operational authority that supports scalable, home‑based acute care and online diabetes prevention services, respectively, with fewer enrollment and location constraints.
- Nonprofit and community providers (FQHCs and RHCs) — preserve payment parity pathways that allow ongoing provision of telehealth without reverting to interim fee‑for‑service treatments that could reduce revenue stability.
- Patients with limited English proficiency — stand to get clearer HHS guidance that, if followed, can improve interpretation workflows, multilingual communications, and accessibility for telehealth services.
Who Bears the Cost
- Durable medical equipment suppliers and certain prosthetics/orthotics providers — face higher audit and prepayment review risk starting on the statutory effective date, increasing administrative burden and potential cash‑flow disruptions.
- Hospices and their billing departments — must implement new modifiers and update claims workflows, with transitional training, system upgrades, and potential short‑term claim rejections if coding is inconsistent.
- Hospitals running hospital‑at‑home programs — will need to collect and share granular outcome, staffing, and cost data for the mandated study; that reporting and data infrastructure has operational and personnel costs.
- Clinical diagnostic laboratories — may be subject to heightened scrutiny and potential operational changes following the OIG report, including monitoring for order patterns and modifier usage that could trigger audits.
- CMS and its contractors — will need to absorb increased oversight tasks (master‑list maintenance, prepayment review operations, study execution, guidance development) without an explicit appropriation in the bill, creating potential resource strain.
Key Issues
The Core Tension
The central dilemma is access versus assurance: the bill preserves and extends temporary flexibilities that increase access to virtual and home‑based Medicare services for vulnerable beneficiaries, while simultaneously adding program‑integrity mechanisms that increase audit risk and administrative complexity; choosing how tightly to police claims without unintentionally blocking legitimate care is the decision point with no clean technical fix.
The bill balances two strong policy priorities—preserving access to virtual and home‑based care while tightening program‑integrity tools—but leaves significant implementation questions to CMS. Key uncertainties include the substantive criteria CMS will use to identify ‘‘aberrant’’ DME billing patterns and how aggressively prepayment review will be deployed without chilling legitimate prescribing.
The DME provision’s 24‑month prior‑relationship filter creates a blunt cutoff that could flag appropriate episodic care (e.g., emergency specialists) unless CMS develops nuanced exceptions.
The mandated hospital‑at‑home study is detailed but methodologically challenging: comparators, risk adjustment, and selection‑bias controls will determine whether findings generalize. Hospitals that have used the program selectively for lower‑acuity cases may look better on outcomes and cost metrics than if the program were broadly available, which could bias CMS’s policy response.
The expansion of virtual MDPP and LEP guidance improves access but relies heavily on nonbinding guidance and contractor capacity; absent funding or enforceable standards, the guidance’s impact may be uneven. Finally, the hospice modifier requirement introduces a hard coding deadline that could trigger claim denials if hospices cannot operationalize the change rapidly, underscoring the perennial tradeoff between swift policy pivots and administrative readiness.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.